Publication Year

Gujral JS, Proctor DM, Su SH, Fedoruk JM. 2011. Water adherence factors for human skin. Risk Analysis 31(8):1271-1280; doi: 10.1111/j.1539-6924.2011.01601.x.

Willems SS, Sheppard AM, Treichel JL, Raabe H, Curren R. An evaluation of the reconstructed human epidermis (RhE) method for predicting skin corrosivity of chemical products with extreme acid pH. World Congress, Canada, 2011.

Kreider ML, Panko JM, McDonald JD, McAtee BL, Finley BL, Seagrave J. Effects of intratracheal instillation of tire and road wear particles (TRWP) and tread particles (TP) on inflammation and cytotoxicity in rat lung: A comparative toxicity study. Society of Toxicology Annual Meeting, Washington, D.C., 2011.

Grespin ME, Le MH, Panko JM. Safety data sheet alteration during alignment with the Globally Harmonized System of Classification (GHS) and implications for chemical manufacturers, suppliers and distributors. Society for Risk Analysis Annual Meeting, Charleston, SC, December 2011.

Hitchcock KM, Panko JM, Scott PK. The chemical footprint: An emerging indicator of environmental performance. Society for Environmental Toxicology and Chemistry, Boston, MA, November 2011.

Gaffney SH, Panko JM, Unice KM, Burns AM, Kreider ML, Gelatt RH, Booher LE, Paustenbach DJ. 2011. Occupational exposure to benzene at the ExxonMobil refinery in Baytown, TX (1978-2006). J Exp Sci Environ Epidemiol 21(2):169–185; doi: 10.1038/jes.2009.53.

Marwood C, McAtee BL, Kreider ML, Ogle RS, Finley BL, Sweet LI, Panko JM. 2011. Acute aquatic toxicity of tire and road wear particles to alga, daphnid and fish. Ecotoxicology 20:2079, doi: 10.1007/s10646-011-0750-x.

Panko JM, Hitchcock KM. 2011. Chemical footprint: Enduring product sustainability. EM: AWMA Magazine for Environ Managers, December 12–15.

Thomas RS, Rowlands JC, Budinsky RA, Thompson CM, Urban JD. Dombkowski, A. 2011. Genomic approaches for relative potency assessment. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Cyr PL, Slawsky KL, Olchanski N, Krasa HB, Goss TF, Zimmer C, Hauptman PJ. 2011. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure. Am J Health Syst Pharm 68(4):328-333; doi: 10.2146/ajhp100217.

Pierce JS, Abelmann A, SpicerLJ, Adams RE, GlynnME, Neier K, Finley BL, Gaffney SH. 2011. Characterization of formaldehyde exposure resulting from the use of four professional hair straightening products. J Occup Environ Hyg 8(11):686–699; doi: 10.1080/15459624.2011.626259. PMID: 22035353.

Beyer BK, Chernoff N, Danielsson BR, Davis K -Bruno, Harrouk W, Hood RD, Janer G, Wändel Liminga U, Kim J, Rocca M, Rogers JM, Scialli AR. 2011. Maternal toxicity and its impact on study design and data interpretation. Birth Defects Res B 92(1):36–51; doi: 10.1002/bdrb.20281.

Grace CE, Kim SJ, Rogers JM. 2011. Maternal influences on epigenetic programming of the developing hypothalamic-pituitary-adrenal axis. Birth Defects Res A 91:797–805; doi: 10.1002/bdra.20824.

Lau C, Rogers JM, Desai M, Ross MG. 2011. Fetal programming of adult disease: Implications for prenatal care. Obstet Gynecol 117(4):978–985; doi: 10.1097/AOG.0b013e318212140e.

Wikoff DS, Thompson C, Walker N, DeVito M, Harris M, Birnbaum L, Haws L. Derivation of relative potency estimates using benchmark dose modeling: A case study with TCDF. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Rowlands JC, Urban JD, Wikoff DS, Budinsky RA. 2011. An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon receptor-interacting protein (AIP) gene. Drug Metab Pharmacokinet 26(4):431-439; doi: 10.2133/dmpk.DMPK-11-SC-013.

Datta T, Racz L, Kotay SM, Goel R. 2011. Seasonal variations of nitrifying community in trickling filter-solids contact (TF/SC) activated sludge systems. Bioresource Technol 102(3):2272–2279; doi: 10.1016/j.biortech.2010.10.043.

Budinsky R, Urban J, Rowlands JC. 2011. An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon receptor nuclear translocator gene. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Sheehan PJ, Brorby GP, Berman DW, Bogen KT, Holm SE. 2011. Chamber for testing asbestos-containing products: Validation and testing of a re-created chrysotile-containing joint compound.  Ann Occup Hyg 55(7):797-809; doi: 10.1093/annhyg/mer048.

Thompson CM, Grafström RC. 2011. Considerations for the implausibility of leukemia induction by formaldehyde. Toxicol Sci 120(1):230-232; doi: 10.1093/toxsci/kfq340.